APA (7th ed.) Citation

M, d. L., DM, C., D, G., MA, R., A, Z., K, B., . . . J, M. (2026). Angioedema due to acquired C1 inhibitor deficiency: Patient experience, conceptual disease model, and assessment of patient-reported outcome measures. Frontiers in immunology, 17, 1810851. https://doi.org/10.3389/fimmu.2026.1810851

Chicago Style (17th ed.) Citation

M, de Lange, et al. "Angioedema Due to Acquired C1 Inhibitor Deficiency: Patient Experience, Conceptual Disease Model, and Assessment of Patient-reported Outcome Measures." Frontiers in Immunology 17 (2026): 1810851. https://doi.org/10.3389/fimmu.2026.1810851.

MLA (9th ed.) Citation

M, de Lange, et al. "Angioedema Due to Acquired C1 Inhibitor Deficiency: Patient Experience, Conceptual Disease Model, and Assessment of Patient-reported Outcome Measures." Frontiers in Immunology, vol. 17, 2026, p. 1810851, https://doi.org/10.3389/fimmu.2026.1810851.